EMA receives AstraZeneca vaccine application – massive quantities of vaccines will arrive in Q2 S.Galina says

The European Medicine Agency, EMA, announced this morning that has finally received “an application for conditional marketing authorisation (CMA) for a COVID-19 vaccine developed by AstraZeneca and Oxford University”.

According to a written statement EMA will assess the vaccine under what they call “an accelerated timeline”.

“An opinion on the marketing authorisation could be issued by 29 January during the meeting of EMA’s scientific committee for human medicines (CHMP), provided that the data submitted on the quality, safety and efficacy of the vaccine are sufficiently robust and complete and that any additional information required to complete the assessment is promptly submitted”, EMA notes in its statement.

Source: Cyprus News Agency